'Affordable' Russian Rituximab Biosimilar On Course In India

02:47 EDT 29 Jun 2017 | SCRIP

Biocad’s biosimilar rituximab appears headed for an Indian debut amid significant competition but the Russian firm appears confident that its...


Related Stories


Original Article: 'Affordable' Russian Rituximab Biosimilar On Course In India


More From BioPortfolio on "'Affordable' Russian Rituximab Biosimilar On Course In India"

Quick Search

Relevant Topics

Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...